Miriam E. Tucker

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the clinical trials.

Danish startup company’s combined hand scanner and artificial intelligence analyzer perform similarly to human rheumatologists in determining joint severity.

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Diabetes Drug Class May Reduce Need for Gout Medications

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan condition.

Increasingly, the burden falls on low- and middle-income countries.

If current trends continue, more than 250 million Americans will have overweight or obesity in the next quarter-century.

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity and heart failure.

New findings demonstrated people with obesity rationing medications, a lack of Medicaid coverage in many US states, and the emotional aftermath of coverage loss.

New findings demonstrated people with obesity rationing medications, a lack of Medicaid coverage in many US states, and the emotional aftermath of coverage loss.

Lower dose appears equivalent to 50 mg oral and 2.4 mg injected for weight loss and other outcomes.

Nearly half reported decreased drinking after initiating any anti-obesity medication, including second-generation GLP-1 receptor agonists.

Survey at a safety net hospital finds that not all providers are knowledgeable about, or feel comfortable with, providing comprehensive obesity care.

A document to be published in Lancet Diabetes & Endocrinology will redefine obesity as a condition of excess adiposity, and “clinical obesity” as a disease.

At 3 years in SURMOUNT-1, more than 90% of people remained diabetes-free with tirzepatide and maintained their initial weight loss, but the benefits reverted after the drug was stopped.

A new analysis from Novo Nordisk’s SELECT trial points to the potential for cost savings.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain conditions.

A new consensus statement offers “considerations and good practice points” for the use of continuous glucose monitoring systems in hospital settings.

American Diabetes Association Advises on Hospital CGM Use

Following a low-carbohydrate diet raised C-peptide levels, with a greater increase observed in African Americans.